• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无绳、非血接触式心脏支持的肌肉动力反搏:通向目的地治疗的途径。

Muscle-Powered Counterpulsation for Untethered, Non-Blood-Contacting Cardiac Support: A Path to Destination Therapy.

出版信息

IEEE Trans Biomed Eng. 2020 Nov;67(11):3035-3047. doi: 10.1109/TBME.2020.2974826. Epub 2020 Feb 18.

DOI:10.1109/TBME.2020.2974826
PMID:32086191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7587079/
Abstract

Conventional long-term ventricular assist devices continue to be extremely problematic due to infections caused by percutaneous drivelines and thrombotic events associated with the use of blood-contacting surfaces. Here we describe a muscle-powered cardiac assist device that avoids both these problems by using an internal muscle energy converter to drive a non-blood-contacting extra-aortic balloon pump. The technology was developed previously in this lab and operates by converting the contractile energy of the latissimus dorsi muscle into hydraulic power that can be used, in principle, to drive any blood pump amenable to pulsatile actuation. The two main advantages of this implantable power source are that it 1) significantly reduces infection risk by avoiding a constant skin wound, and 2) improves patient quality-of-life by eliminating all external hardware components. The counterpulsatile balloon pumps, which compress the external surface of the ascending aorta during the diastolic phase of the cardiac cycle, offer another critical advantage in the setting of long-term circulatory support in that they increase cardiac output and improve coronary perfusion without touching the blood. The goal of this work is to combine these two technologies into a single circulatory support system that eliminates driveline complications and avoids surface-mediated thromboembolic events, thereby providing a safe, tether-free means to support the failing heart over extended - or even indefinite - periods of time.

摘要

由于经皮驱动轴引起的感染和与血液接触表面相关的血栓事件,传统的长期心室辅助装置仍然存在极大的问题。在这里,我们描述了一种肌肉驱动的心脏辅助装置,它通过使用内部肌肉能量转换器来驱动非血液接触的主动脉外球囊泵,避免了这两个问题。这项技术是由本实验室之前开发的,它的工作原理是将背阔肌的收缩能量转化为液压能,原则上可以驱动任何可进行脉动驱动的血液泵。这种可植入电源有两个主要优点:1)通过避免持续的皮肤伤口,大大降低了感染风险;2)通过消除所有外部硬件组件,提高了患者的生活质量。反搏球囊泵在心脏周期的舒张期压缩升主动脉的外表面,在长期循环支持的情况下提供了另一个关键优势,因为它们在不接触血液的情况下增加心输出量和改善冠状动脉灌注。这项工作的目标是将这两种技术结合成一个单一的循环支持系统,消除驱动轴并发症,并避免表面介导的血栓栓塞事件,从而提供一种安全、无束缚的方法来在延长的甚至是无限期的时间内支持衰竭的心脏。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/dabe1f284d1f/nihms-1583131-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/e740ed5ccbe8/nihms-1583131-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/689735d40f70/nihms-1583131-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/32f8607ac463/nihms-1583131-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/144fe3f937c3/nihms-1583131-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/17efd4a9ca22/nihms-1583131-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/dc560beb7e71/nihms-1583131-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/6990493cd277/nihms-1583131-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/0721d4c26dfb/nihms-1583131-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/164782d98028/nihms-1583131-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/5f79fd9d1b9d/nihms-1583131-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/6cdd13d15c31/nihms-1583131-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/dabe1f284d1f/nihms-1583131-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/e740ed5ccbe8/nihms-1583131-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/689735d40f70/nihms-1583131-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/32f8607ac463/nihms-1583131-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/144fe3f937c3/nihms-1583131-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/17efd4a9ca22/nihms-1583131-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/dc560beb7e71/nihms-1583131-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/6990493cd277/nihms-1583131-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/0721d4c26dfb/nihms-1583131-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/164782d98028/nihms-1583131-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/5f79fd9d1b9d/nihms-1583131-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/6cdd13d15c31/nihms-1583131-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c96/7587079/dabe1f284d1f/nihms-1583131-f0012.jpg

相似文献

1
Muscle-Powered Counterpulsation for Untethered, Non-Blood-Contacting Cardiac Support: A Path to Destination Therapy.无绳、非血接触式心脏支持的肌肉动力反搏:通向目的地治疗的途径。
IEEE Trans Biomed Eng. 2020 Nov;67(11):3035-3047. doi: 10.1109/TBME.2020.2974826. Epub 2020 Feb 18.
2
Potential mechanisms for muscle-powered cardiac support.肌肉驱动的心脏辅助的潜在机制。
Artif Organs. 2011 Jul;35(7):715-20. doi: 10.1111/j.1525-1594.2010.01170.x. Epub 2011 May 22.
3
Muscle powered circulatory assist device for diastolic counterpulsator.用于舒张期反搏器的肌肉动力循环辅助装置。
ASAIO Trans. 1989 Jul-Sep;35(3):408-11. doi: 10.1097/00002480-198907000-00076.
4
Implantable rate-responsive counterpulsation assist system.植入式频率响应型反搏辅助系统。
Ann Thorac Surg. 1990 Mar;49(3):356-61; discussion 361-2. doi: 10.1016/0003-4975(90)90238-2.
5
A new skeletal muscle linear-pull energy convertor as a power source for prosthetic circulatory support devices [corrected].一种新型骨骼肌线性牵引能量转换器作为人工循环支持装置的动力源[已修正]
J Heart Lung Transplant. 1992 Sep-Oct;11(5):S341-50.
6
The muscle-powered dual-chamber counterpulsator: rheologically superior implantable cardiac assist device.肌肉驱动双腔反搏器:流变学性能更优的植入式心脏辅助装置。
Ann Thorac Surg. 1988 Jun;45(6):620-5. doi: 10.1016/s0003-4975(10)64762-5.
7
Efficacy of a biomechanical counterpulsation device powered by skeletal muscle for right heart assist.一种由骨骼肌驱动的生物力学反搏装置用于右心辅助的疗效。
ASAIO Trans. 1990 Jul-Sep;36(3):M389-92.
8
A new implantable burst generator for skeletal muscle powered aortic counterpulsation.一种用于骨骼肌驱动主动脉反搏的新型植入式脉冲发生器。
ASAIO Trans. 1989 Jul-Sep;35(3):405-7. doi: 10.1097/00002480-198907000-00075.
9
A compressive type skeletal muscle pump as a biomechanical energy source.一种作为生物机械能来源的压缩式骨骼肌泵。
ASAIO J. 1996 Sep-Oct;42(5):M637-41. doi: 10.1097/00002480-199609000-00065.
10
Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations.心脏辅助装置:早期概念、当前技术与未来创新
Bioengineering (Basel). 2019 Feb 15;6(1):18. doi: 10.3390/bioengineering6010018.

本文引用的文献

1
The ascending aortic aneurysm: When to intervene?升主动脉瘤:何时进行干预?
Int J Cardiol Heart Vasc. 2015 Jan 20;6:91-100. doi: 10.1016/j.ijcha.2015.01.009. eCollection 2015 Mar 1.
2
Ventricle-specific epicardial pressures as a means to optimize direct cardiac compression for circulatory support: A pilot study.作为优化直接心脏按压以支持循环的手段,心室特异性心外膜压力:一项初步研究。
PLoS One. 2019 Jul 5;14(7):e0219162. doi: 10.1371/journal.pone.0219162. eCollection 2019.
3
Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations.
心脏辅助装置:早期概念、当前技术与未来创新
Bioengineering (Basel). 2019 Feb 15;6(1):18. doi: 10.3390/bioengineering6010018.
4
Diagnosis and management of supraventricular tachycardias.室上性心动过速的诊断与管理
CMAJ. 2016 Dec 6;188(17-18):E466-E473. doi: 10.1503/cmaj.160079. Epub 2016 Oct 24.
5
Antihypertensive efficacy and safety of the angiotensin receptor blocker azilsartan in elderly patients with hypertension.血管紧张素受体阻滞剂阿齐沙坦在老年高血压患者中的降压疗效及安全性
Drug Chem Toxicol. 2017 Jan;40(1):110-114. doi: 10.1080/01480545.2016.1188301. Epub 2016 Jul 17.
6
Preliminary Results From the C-Pulse OPTIONS HF European Multicenter Post-Market Study.C-Pulse OPTIONS HF欧洲多中心上市后研究的初步结果
Med Sci Monit Basic Res. 2016 Feb 18;22:14-9. doi: 10.12659/MSMBR.896959.
7
Management of tachycardia.心动过速的管理
F1000Prime Rep. 2015 May 12;7:60. doi: 10.12703/P7-60. eCollection 2015.
8
Atherosclerosis: process, indicators, risk factors and new hopes.动脉粥样硬化:进程、指标、风险因素与新希望
Int J Prev Med. 2014 Aug;5(8):927-46.
9
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.心力衰竭住院患者的全球健康和经济负担:从心力衰竭住院登记中吸取的经验教训。
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133. doi: 10.1016/j.jacc.2013.11.053. Epub 2014 Feb 5.
10
Intra-aortic balloon counterpulsation - basic principles and clinical evidence.主动脉内球囊反搏 - 基本原理和临床证据。
Vascul Pharmacol. 2014 Feb;60(2):52-6. doi: 10.1016/j.vph.2013.12.003. Epub 2013 Dec 28.